16 December 2022: Original Paper
Acute Pancreatitis in Patients After Liver Transplantation
Alzbeta Hujova 1BCDEF , Peter Macinga 1AEF , Jana Jarosova 1E , Jiri Fronek 2A , Pavel Taimr 1A , Julius Spicak 1A , Tomas Hucl 1ACDEF*DOI: 10.12659/AOT.938114
Ann Transplant 2022; 27:e938114
Table 3 Etiology of liver disease as an indication for OLTx in relation to AP.
| OLTx without AP | OLTx with AP | |||
|---|---|---|---|---|
| 1801 | 49 | |||
| n | % | n | % | |
| Alcohol | 21.2 | 14.3 | ||
| HCV | 8.2 | 14.3 | ||
| HCC | 15.9 | 12.2 | ||
| PSC | 10.5 | 8.2 | ||
| PBC | 5.8 | 4.1 | ||
| Auto-immune | 4.0 | 10.2 | ||
| Cryptogenic+NASH | 8.6 | 8.2 | ||
| Wilson’s disease | 1.0 | 0 | ||
| HBV | 2.5 | 14.3 | ||
| Polycystosis | 4.2 | 4.1 | ||
| Other tumours | 2.9 | 0 | ||
| Biliary atresia | 2.5 | 2.0 | ||
| Metabolic diseases | 1.9 | 2.0 | ||
| FHF | 9.9 | 2.0 | ||
| Other | 9.4 | 6.1 | ||
| OLTx – orthotopic liver transplantation; HCV – hepatitis C cirrhosis; HCC – hepatocellular carcinoma; PSC – primary sclerosing cholangitis; PBC – primary biliary cholangitis; NASH – non-alcoholic steatohepatitis; HBV – hepatitis B cirrhosis; FHF – fulminant hepatic failure. | ||||